United States:
FDA Proposes To Amend Regulations For Embryo Donation And Related Labeling
21 January 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the December 31, 2015, Federal Register,
FDA proposed amendments to the human cells, tissues, and cellular
and tissue-based products (HCT/Ps) regulations regarding donor
eligibility and related labeling for human embryos. FDA is
proposing the revisions in response to comments from stakeholders
regarding the importance of embryos to individuals and couples
seeking access to donated embryos. Comments due March
31, 2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
